In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees (Q44027116)

29 November 2017

In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees (English)

1 reference

29 November 2017

1 reference

1 reference

Hyo Jeong Hong

1

1 reference

29 November 2017

Chun Jeih Ryu

2

1 reference

29 November 2017

Hyangsuk Hur

3

1 reference

29 November 2017

Seho Kim

4

1 reference

29 November 2017

Han Kyu Oh

5

1 reference

29 November 2017

Mee Sook Oh

6

1 reference

29 November 2017

Song Yong Park

7

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

29 November 2017

1 reference

29 November 2017

318

1 reference

29 November 2017

134-141

1 reference

29 November 2017

1

1 reference

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

In vivo activity of a mixture of two human monoclonal antibodies (anti-HBs) in a chronic hepatitis B virus carrier chimpanzee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Genetic and molecular basis for T- and B-cell recognition of hepatitis B viral antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

A humanized antibody that binds to the interleukin 2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Monoclonal antibodies in the clinic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Reshaping human antibodies for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

An 80-kilodalton protein that binds to the pre-S1 domain of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Mouse monoclonal antibodies to hepatitis B virus preS1 produced after immunization with recombinant preS1 peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2003.09.014

1 reference

29 November 2017

1 reference